Intrathecal inflammation precedes development of Alzheimer's disease

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,803 · see citing works

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,003 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. L., & Stadlan, E. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 9,882 · see citing works

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,152 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

The acute phase response

Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907 · see citing works

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works

Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>

Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · see citing works

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846 · see citing works

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836 · see citing works

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S.-H. C., & Brosnan, C. F. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 821 · see citing works

tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?

Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789 · see citing works

Apolipoprotein E Status as a Predictor of the Development of Alzheimer's Disease in Memory-Impaired Individuals

Petersen, R. C. (1995) · JAMA · doi:10.1001/jama.1995.03520400044042 · Cited by 783 · see citing works

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 729 · see citing works

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

Cheng, B., Christakos, S., & Mattson, M. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90159-7 · Cited by 660 · see citing works

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease

Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660 · see citing works

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 625 · see citing works

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 591 · see citing works

Tumor necrosis factor.

井上, 守., 猪子, 英., & 辻, 公. (1992) · Medical Entomology and Zoology · Cited by 584 · see citing works

Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent

Thomas, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.603 · Cited by 556 · see citing works

Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

Relton, J. K., & Rothwell, N. J. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90033-t · Cited by 548 · see citing works

Immune System Response in Alzheimer's Disease

McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 460 · see citing works

High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

Galasko, D., Chang, L., Motter, R., Clark, C. M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.937 · Cited by 442 · see citing works

Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease

Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · see citing works

Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia

Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · see citing works

Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia

Tarkowski, E., Blennow, K., Wallin, A., & Tarkowski, A. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020568013953 · Cited by 349 · see citing works

Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro.

Suzumura, A., Sawada, M., Yamamoto, H., & Marunouchi, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2150 · Cited by 305 · see citing works

Increased Expression of TGF-β1 in Brain Tissue After Ischemic Stroke in Humans

Krupiński, J., Kumar, P., Kumar, S., & Kałuza, J. (1996) · Stroke · doi:10.1161/01.str.27.5.852 · Cited by 282 · see citing works

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?

Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264 · see citing works

Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

Andreasen, N. C., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B. G., & Blennow, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00617-5 · Cited by 236 · see citing works

Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edema

Holmin, S., & Mathiesen, T. I. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.1.0108 · Cited by 230 · see citing works

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

Andreasen, N. C., Vanmechelen, E., VOORDE, A. V. D., Davidsson, P., Hesse, C., Tarvonen-Schröder, S., Räihä, I. J., Sourander, L., Winblad, B. G., & Blennow, K. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.298 · Cited by 227 · see citing works

Cytokines in Health and Disease

Kunkel, S. L., & Remick, D. G. (1992) · Medical Entomology and Zoology · Cited by 197 · see citing works

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals

Petersen, R. C. (1995) · JAMA · doi:10.1001/jama.273.16.1274 · Cited by 134 · see citing works

Differential regulation of astrocyte TNF‐α expression by the cytokines TGF‐β, IL‐6 and IL‐10

Benveniste, E. N., Tang, L. P., & Law, R. M. (1995) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)00061-7 · Cited by 132 · see citing works

Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta.

Behzadian, M. A., Wang, X., Al‐Shabrawey, M., Shabrawey, M., & Caldwell, R. B. (1998) · PubMed · Cited by 118 · see citing works

Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro

Koochekpour, S., Merzak, A., & Pilkington, G. J. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04161-4 · Cited by 117 · see citing works

Tumor necrosis factor facilitates regeneration of injured central nervous system axons

Schwartz, M., Solomon, A., Lavie, V., Ben-Bassat, S., Belkin, M., & Cohen, A. (1991) · Brain Research · doi:10.1016/0006-8993(91)91309-o · Cited by 115 · see citing works

Cytokines and the CNS

Ransohoff, R. M., & Benveniste, E. N. (2005) · CRC Press eBooks · doi:10.1201/9781420039849 · Cited by 110 · see citing works

Localization of Interleukin-1 Receptor Antagonist mRNA in Rat Brain

Licinio, J., Wong, M., & Gold, P. W. (1991) · Endocrinology · doi:10.1210/endo-129-1-562 · Cited by 106 · see citing works

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

Bauer, J., Ganter, U., Strauss, S., Stadtmüller, G., Frommberger, U., Bauer, H. C., Volk, B., & Berger, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80051-l · Cited by 101 · see citing works

Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia

Tarkowski, E., Wallin, A., Regland, B., Blennow, K., & Tarkowski, A. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.103003166.x · Cited by 91 · see citing works

Progress in Alzheimer’s and Parkinson’s Diseases

(1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3 · Cited by 80 · see citing works

Development of a Specific Diagnostic Test for Measurement of β-Amyloid (1-42) [βA4(l-42)] in CSF

Vanderstichele, H., Blennow, K., D'Heuvaert, N., Buyse, M.-A., Wallin, A., Andreasen, N. C., Seubert, P. A., VOORDE, A. V. D., & Vanmechelen, E. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_110 · Cited by 70 · see citing works

Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden

Andreasen, N., Blennow, K., Sjödin, C., Winblad, B. G., & Svärdsudd, K. (1999) · Neuroepidemiology · doi:10.1159/000026206 · Cited by 64 · see citing works

Localization of p75 neurotrophin receptor in the retina of the adult SD rat: An immunocytochemical study at light and electron microscopic levels

Hu, B., Yip, H. K.-F., & So, K. (1998) · Glia · doi:10.1002/(sici)1098-1136(199810)24:2 · Cited by 58 · see citing works

TNF gene polymorphism and its relation to intracerebral production of TNFα and TNFβ in AD

Tarkowski, E., Liljeroth, A., Nilsson, A. M., Ricksten, A., Davidsson, P., Minthon, L., & Blennow, K. (2000) · Neurology · doi:10.1212/wnl.54.11.2077 · Cited by 53 · see citing works

Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.

Sutton, E. T., Thomas, T., Bryant, M., Landon, C. S., Newton, C., & Rhodin, J. A. G. (1999) · PubMed · Cited by 46 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595 · see citing works

Immune attack: the role of inflammation in Alzheimer disease

Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · see citing works

Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases

Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967 · see citing works

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · see citing works

Mediterranean Diet and Mild Cognitive Impairment

Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757 · see citing works

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 493 · see citing works

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447 · see citing works

Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis

Iosif, R. E., Ekdahl, C. T., Ahlenius, H., Pronk, C. J., Bonde, S., Kokaia, Z., Jacobsen, S. E. W., & Lindvall, O. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-06.2006 · Cited by 462 · see citing works

Therapeutic strategies for Alzheimer's disease in clinical trials

Godyń, J., Jończyk, J., Panek, D., & Malawska, B. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.07.006 · Cited by 454 · see citing works

Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan

Johnson, E. J. (2014) · Nutrition Reviews · doi:10.1111/nure.12133 · Cited by 444 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Particulate Matter in Polluted Air May Increase Biomarkers of Inflammation in Mouse Brain

Campbell, A., Oldham, M. J., Becaria, A., Bondy, S. C., Meacher, D. M., Sioutas, C., Misra, C., Méndez, L. B., & Kleinman, M. T. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.08.003 · Cited by 422 · see citing works

Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice

He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390 · see citing works

Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10)

Lively, S. S., & Schlichter, L. C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00215 · Cited by 384 · see citing works

RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease

Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395 · see citing works

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335 · see citing works

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289 · see citing works

Lipoic acid as a novel treatment for Alzheimer's disease and related dementias

Holmquist, L., Stuchbury, G., Berbaum, K., Muscat, S., Young, S. A., Häger, K., Engel, J., & Münch, G. W. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.001 · Cited by 289 · see citing works

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease

Álvarez, A., Cacabelos, R., Sanpedro, C., García-Fantini, M., & Aleixandre, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.012 · Cited by 278 · see citing works

MicroRNAs: Roles in Regulating Neuroinflammation

Gaudet, A. D., Fonken, L. K., Watkins, L. R., Nelson, R. J., & Popovich, P. G. (2017) · The Neuroscientist · doi:10.1177/1073858417721150 · Cited by 270 · see citing works

TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.

Tobinick, E. L., Gross, H., Weinberger, A., & Cohen, H. (2006) · PubMed Central · Cited by 271 · see citing works

A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development

Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268 · see citing works

Relationship between Serum and Brain Carotenoids, α -Tocopherol, and Retinol Concentrations and Cognitive Performance in the Oldest Old from the Georgia Centenarian Study

Johnson, E. J., Vishwanathan, R., Johnson, M. A., Hausman, D. B., Davey, A., Scott, T. M., Green, R. C., Miller, L. S., Gearing, M., Woodard, J. L., et al. (2013) · Journal of Aging Research · doi:10.1155/2013/951786 · Cited by 268 · see citing works

Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease

Rajesh, Y., & Kanneganti, T. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 261 · see citing works

TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia

Lee, J.-W., Nam, H., Kim, L. E., Jeon, Y., Min, H., Ha, S., Lee, Y., Kim, S.-Y., Lee, S. J., Kim, E.-K., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1556946 · Cited by 260 · see citing works

Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders

Von Bernhardi, R., Tichauer, J. E., & Eugenín, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06537.x · Cited by 258 · see citing works

Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

Tobinick, E. L., & Gross, H. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-2 · Cited by 247 · see citing works

PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease

Alkon, D. L., Sun, M., & Nelson, T. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.002 · Cited by 243 · see citing works

Tau in neurodegenerative disease

Gao, Y.-L., Wang, N., Sun, F.-R., Cao, X.-P., Zhang, W., & Yu, J.-T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.23 · Cited by 222 · see citing works

TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus

Jayaraman, A., Htike, T. T., James, R., Picón, C., & Reynolds, R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01264-w · Cited by 239 · see citing works

The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease

Hanslik, K. L., & Ulland, T. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.570711 · Cited by 236 · see citing works

The roles of TNF in brain dysfunction and disease

Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232 · see citing works

Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell deathin rats

Tanaka, S., Ide, M., Shibutani, T., Ohtaki, H., Numazawa, S., Shioda, S., & Yoshida, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20752 · Cited by 224 · see citing works

Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease

Galasko, D. R., & Montine, T. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.89 · Cited by 221 · see citing works

Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains

Shi, J.-Q., Shen, W., Chen, J., Wang, B.-R., Zhong, L.-L., Zhu, Y.-W., Zhu, H.-Q., Zhang, Q.-Q., Zhang, Y.-D., & Xu, J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.053 · Cited by 219 · see citing works

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C., Bresolin, N., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.007 · Cited by 209 · see citing works

Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206 · see citing works

A possible role for lutein and zeaxanthin in cognitive function in the elderly

Johnson, E. J. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.034611 · Cited by 207 · see citing works

Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

Tweedie, D., Ferguson, R. A., Fishman, K., Frankola, K. A., van Praag, H., Holloway, H. W., Luo, W., Li, Y., Caracciolo, L., Russo, I., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-106 · Cited by 204 · see citing works

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

Castaño, E. M., Roher, A. E., Esh, C. L., Kokjohn, T. A., & Beach, T. G. (2006) · Neurological Research · doi:10.1179/016164106x98035 · Cited by 201 · see citing works

Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis

Chou, R. C., Kane, M., Ghimire, S., Gautam, S., & Gui, J. (2016) · CNS Drugs · doi:10.1007/s40263-016-0374-z · Cited by 194 · see citing works

Tumor necrosis factor α Inhibition for Alzheimer’s Disease

Chang, R., Yee, K.-L., & Sumbria, R. K. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517709278 · Cited by 195 · see citing works

Reactive astrocytes in Alzheimer’s disease: A double-edged sword

Chun, H., & Lee, C. J. (2018) · Neuroscience Research · doi:10.1016/j.neures.2017.11.012 · Cited by 176 · see citing works

Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications

Si, Z.-Z., Zou, C.-J., Mei, X., Mei, X., Luo, H., Shen, Y., Hu, J., Li, X.-X., Wu, L., & Liu, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.353484 · Cited by 192 · see citing works

Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death

Kauppinen, T. M., & Swanson, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2288 · Cited by 181 · see citing works

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease

Bermejo, P., Martín-Aragón, S., Benedí, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.02.002 · Cited by 178 · see citing works

Altered plasma cytokine levels in Alzheimer's disease: Correlation with the disease progression

Motta, M., Imbesi, R., Rosa, M. D., Stivala, F., & Malaguarnera, L. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.09.002 · Cited by 176 · see citing works

NETosis in Alzheimer’s Disease

Pietronigro, E. C., Bianca, V. D., Zenaro, E., & Constantin, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00211 · Cited by 176 · see citing works

The GABAergic system as a therapeutic target for Alzheimer's disease

Guzmán, B. C., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 170 · see citing works

Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

Diniz, B. S., Pinto, J. A., & Forlenza, O. V. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701535502 · Cited by 168 · see citing works

Inflammation, Neurodegenerative Diseases, and Environmental Exposures

Campbell, A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.008 · Cited by 163 · see citing works

Clinical aspects of inflammation in Alzheimer's disease

Rosenberg, P. B. (2005) · International Review of Psychiatry · doi:10.1080/02646830500382037 · Cited by 159 · see citing works

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

Zhou, M., Xu, R., Kaelber, D. C., & Gurney, M. E. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229819 · Cited by 157 · see citing works

Increased production of inflammatory cytokines in mild cognitive impairment

Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 156 · see citing works

Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158 · see citing works

TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG

Xu, C., Wu, J. S., Wu, Y., Ren, Z., Yao, Y., Chen, G., Fang, E. F., Noh, J. H., Liu, Y., Wei, L., et al. (2021) · Theranostics · doi:10.7150/thno.62376 · Cited by 151 · see citing works

Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study

Oberstein, T. J., Taha, L., Spitzer, P., Hellstern, J., i, M. H., Kornhuber, J., & Maler, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01213 · Cited by 149 · see citing works

Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design

van Rossum, I. A., Vos, S. J. B., Handels, R. L. H., & Visser, P. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091606 · Cited by 143 · see citing works

Alzheimer's disease: Effects of β-amyloid on mitochondria

Tillement, L., Lecanu, L., & Papadopoulos, V. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.08.009 · Cited by 145 · see citing works

Systemic TNF-α produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration

Hennessy, E., Gormley, S., López-Rodríguez, A. B., Murray, C., Murray, C., & Cunningham, C. M. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.011 · Cited by 142 · see citing works

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

Teixeira, A. L., Diniz, B. S., Campos, A. C., de Miranda, A. S., Rocha, N. P., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8201-2 · Cited by 140 · see citing works

TNF-α-Induced Optic Nerve Degeneration and Nuclear Factor-κB p65

Kitaoka, Y., Kitaoka, Y., Kwong, J. M. K., Ross‐Cisneros, F. N., Wang, J., Tsai, R., Sadun, A. A., & Lam, T. T. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0299 · Cited by 135 · see citing works

Cerebrospinal fluid markers of neuroinflammation in delirium: A role for interleukin-1β in delirium after hip fracture

Cape, E., Hall, R. J., Munster, B. C. V., de Vries, A., Howie, S., Pearson, A., Middleton, S. D., Gillies, F., Armstrong, I. R., White, T. O., et al. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.06.014 · Cited by 130 · see citing works

Heat-Shock Proteins in Neuroinflammation

Dukay, B., Csoboz, B., & Tóth, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00920 · Cited by 132 · see citing works

Therapeutic strategies for tau mediated neurodegeneration

Yoshiyama, Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303144 · Cited by 129 · see citing works

Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury

Tobinick, E. L., Kim, N. M., Reyzin, G., Rodriguez-Romanacce, H., & DePuy, V. (2012) · CNS Drugs · doi:10.1007/s40263-012-0013-2 · Cited by 131 · see citing works

Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain

Becaria, A., Lahiri, D. K., Bondy, S. C., Chen, D., Hamadeh, A., Li, H., Taylor, R., & Campbell, A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.025 · Cited by 129 · see citing works

Therapeutic Potential of TNF-α Inhibition for Alzheimer’s Disease Prevention

Torres-Acosta, N., O’Keefe, J. H., O’Keefe, E. L., Isaacson, R., & Small, G. W. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200711 · Cited by 129 · see citing works

Differential contribution of microglia and monocytes in neurodegenerative diseases

Baufeld, C., O'Loughlin, E. K., Calcagno, N., Madore, C., & Butovsky, O. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123 · see citing works

Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122 · see citing works

Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease

Steeland, S., Gorlé, N., Vandendriessche, C., Balusu, S., Brkić, M., Cauwenberghe, C. V., Imschoot, G. V., Wonterghem, E. V., Rycke, R. M. D., Kremer, A., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708300 · Cited by 119 · see citing works

Increased plasma levels of lipocalin 2 in mild cognitive impairment

Choi, J., Lee, H., & Suk, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.023 · Cited by 119 · see citing works

Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence

Tobinick, E. (2009) · CNS Drugs · doi:10.2165/11310810-000000000-00000 · Cited by 117 · see citing works

The Role of TNF-α in Alzheimer’s Disease: A Narrative Review

Plantone, D., Pardini, M., Righi, D., Manco, C., Colombo, B. M., & Stefano, N. D. (2023) · Cells · doi:10.3390/cells13010054 · Cited by 119 · see citing works

Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents

Clark, I. A., & Vissel, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0708-2 · Cited by 123 · see citing works

Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease

Kim, T., Lim, H. K., Lee, J. Y., Kim, D., Park, S., Lee, C., & Lee, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.019 · Cited by 115 · see citing works

Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease

Chang, R., Knox, J., Chang, J. H., Derbedrossian, A., Vasilevko, V., Cribbs, D. H., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00200 · Cited by 113 · see citing works

Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases

Baldacci, F., Lista, S., Cavedo, E., Bonuccelli, U., & Hampel, H. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304217 · Cited by 113 · see citing works

Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept

Page, S. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0057-y · Cited by 112 · see citing works

Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease

Melah, K. E., Lu, S. Y.-F., Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150897 · Cited by 109 · see citing works

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease

Tobinick, E. L., & Gross, H. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-27 · Cited by 111 · see citing works

TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective

Kapoor, M., & Chinnathambi, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02751-8 · Cited by 114 · see citing works

Serum high sensitivity C-reactive protein and cognitive function in elderly women

Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Penttila, I. M., Helkala, E.-L., Gylling, H. K., Nissinen, A. M., & Rauramaa, R. (2007) · Age and Ageing · doi:10.1093/ageing/afm051 · Cited by 109 · see citing works

Dietary carotenoids and cognitive function among US adults, NHANES 2011–2014

Christensen, K. L. Y., Gleason, C. E., & Mares, J. A. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1533199 · Cited by 109 · see citing works

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease

Schmand, B. A., Huizenga, H. M., & van Gool, W. A. (2009) · Psychological Medicine · doi:10.1017/s0033291709991516 · Cited by 109 · see citing works

T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers

Mietelska‐Porowska, A., & Wojda, U. (2017) · Journal of Immunology Research · doi:10.1155/2017/4626540 · Cited by 107 · see citing works

Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines

Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170929 · Cited by 107 · see citing works

Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death

Hughes, C., Choi, M. L., Yi, J.-H., Kim, S.-C., Drews, A., George-Hyslop, P. S., Bryant, C., Gandhi, S., Cho, K., & Klenerman, D. (2020) · Communications Biology · doi:10.1038/s42003-020-0792-9 · Cited by 107 · see citing works

Longitudinal Inflammation, Cognitive Decline, and Alzheimer’s Disease: A Mini-Review

Bettcher, B. M., & Kramer, J. H. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.147 · Cited by 107 · see citing works

Systemic and Acquired Immune Responses in Alzheimer's Disease

Britschgi, M., & Wyss‐Coray, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82011-3 · Cited by 105 · see citing works

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease

Combrinck, M. I. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063131 · Cited by 105 · see citing works

Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells

Ojala, J. O., Sutinen, E. M., Salminen, A., & Pirttilä, T. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.012 · Cited by 102 · see citing works

The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases

Darwish, S. F., Elbadry, A. M. M., Elbokhomy, A. S., Salama, G. A., & Salama, R. M. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1231706 · Cited by 106 · see citing works

Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity

Vincent, A. J., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101089 · Cited by 102 · see citing works

Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer’s disease

Ryan, S. M., & Kelly, A. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.007 · Cited by 104 · see citing works

Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage

Bettcher, B. M., Johnson, S. C., Fitch, R., Casaletto, K. B., Heffernan, K. S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C. M., Neuhaus, J. M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170602 · Cited by 103 · see citing works

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease

Muszyński, P., Groblewska, M., Kulczyńska‐Przybik, A., Kułakowska, A., & Mroczko, B. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170208124324 · Cited by 100 · see citing works

It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease

Arnaud, L. T., Robakis, N. K. R. K., & Figueiredo‐Pereira, M. E. (2006) · Neurodegenerative Diseases · doi:10.1159/000095638 · Cited by 102 · see citing works

Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Diniz, B. S., Teixeira, A. L., Ojopi, E. P. B., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100921 · Cited by 99 · see citing works

P2‐111: CORRELATION OF CEREBROSPINAL FLUID CYTOKINES WITH CLINICAL MARKERS OF DEMENTIA IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE

Brosseron, F., Kummer, M. P., Krauthausen, M., Jessen, F., & Heneka, M. T. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.786

P2–132: Inflammatory markers in MCI and AD patients with different biomarker profiles

Schuitemaker, A., Dik, M. G., Schoonenboom, N. S. M., Kok, A., van Elk, E.-J., Scheltens, P., & Jonker, C. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.970

Cerebrospinal fluid inflammatory markers in amnestic mild cognitive impairment

Rizzi, L., & Roriz‐Cruz, M. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12704 · Cited by 9 · see citing works

Pro-and anti-inflammatory cytokines in cerebrospinal fluid of patients with Alzheimer's disease

Ying-tang, L. (2006) · Journal of Guangdong Medical College

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease

Popp, J., Bacher, M., Kölsch, H., Noelker, C., Deuster, O., Dodel, R. C., & Jessen, F. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.006 · Cited by 91 · see citing works